Business
from24/7 Wall St.
1 day agoTrade Desk Just Got Hit Again: HSBC Downgrades to Reduce With $20 Price Target
HSBC downgraded Trade Desk to Reduce with a $20 price target amid structural concerns about ad spending shifting to walled gardens.
#analyst-downgrades
#analyst-downgrades
[ follow ]
fromFinbold
4 days agoTrade Desk stock falls as mixed earnings trigger price target cuts
As expected, Wall Street was quick to react to the price correction, with multiple firms revising their outlooks on The Trade Desk. For example, Oppenheimer removed its $35 TTD price target and dropped the rating on the shares from 'Outperform' to 'Perform,' arguing that growth won't exceed single-digit figures this quarter.
Business
Gadgets
from24/7 Wall St.
2 months agoQualcomm Drops 21% in 2026 - Is BofA Right to Call It a Sell?
Qualcomm shares declined 21% year-to-date amid analyst downgrades led by Bank of America's Underperform rating, primarily driven by concerns over losing Apple's modem business by 2027 as Apple develops internal chips.
Business intelligence
from24/7 Wall St.
2 months agoWall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit
Multiple analysts downgraded or adjusted targets on Novo Nordisk, Korn Ferry, Jefferies Financial Group, and Talkspace due to pipeline disappointment, valuation compression, clinical trial underperformance, and acquisition-driven resolution.
Business intelligence
from24/7 Wall St.
2 months agoGrocery Outlet and Scholastic Face New Analyst Scrutiny on Consumer Trends
Wall Street shows divergent sentiment on consumer stocks: Grocery Outlet faces structural headwinds with analyst downgrades, while Scholastic is downgraded due to positive news already priced into the market.
Business
from24/7 Wall St.
2 months agoWall Street Just Sent a Clear Signal on GTLB - Nine Analysts Cut Price Targets After FY27 Guidance Disappoints
GitLab's strong Q4 earnings beat was overshadowed by disappointing FY27 guidance showing earnings regression and below-consensus revenue growth, triggering nine analyst price target cuts across the Street.
Healthcare
from24/7 Wall St.
2 months agoNovo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low
Novo Nordisk's stock dropped 22% weekly and 56% yearly after CagriSema trial failure and announced price cuts on flagship drugs, causing analyst downgrades and declining Reddit sentiment.
[ Load more ]